Biotia
Latest round
- Series A
Last raised
- Aug 2022
Total raised
- $11M
Investors
- 15
About Biotia
Biotia, Inc.Biotia, Inc. was founded in 2016 and is headquartered in Brooklyn, US. The company specializes in genomics-based diagnostics, evolving its strategy to provide innovative solutions for infectious diseases. The co-founders include Christopher Mason, Niamh Ohara, and Rachid O, with Niamh Ohara serving as the CEO. In October 2026, Biotia, Inc. Biotia specializes in advanced infectious disease diagnostics powered by genomics and artificial intelligence (AI). The company's primary offerings include BIOTIA-DX and BIOTIA-ID, clinically validated metagenomics tools designed to enhance traditional diagnostic methods. BIOTIA-DX enables precise organism identification with heightened sensitivity, while BIOTIA-ID is a comprehensive assay with regulatory approvals aimed at immunocompromised individuals and those facing complicated infections. Additionally, the BIOTIA-ID Urine assay provides a novel solution to improve detection rates of various pathogens.Biotia generates revenue through direct sales, partnerships, and collaborative agreements with esteemed healthcare institutions, such as the Mayo Clinic and the Rockefeller Foundation. Its key products, BIOTIA-DX and BIOTIA-ID, are sold as laboratory-developed tests (LDTs) to healthcare facilities that incorporate them into their workflows. The company operates on a B2B revenue model, with transactions facilitated through agreements that may involve subscription services or one-time payments for specific assays, enhancing its revenue streams in the infectious disease sector.
Who invested in Biotia
15 investors across 6 rounds
See all investors in Biotia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biotia
Who invested in Biotia?
Biotia has 15 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biotia raised?
Biotia has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Biotia last raise money?
Biotia's most recent round on record is a Series A, in Aug 2022.
What does Biotia do?
Biotia is a healthcare it company.
Where is Biotia headquartered?
Biotia is headquartered in Long Island City, US.
Which VCs invest in companies like Biotia?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Biotia's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Biotia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.